6 JUNE 2007 - IMMEDIATE
MICROFUZE INTERNATIONAL PLC (AIM: MFZ)
("MicroFuze" or "the Company")
Issue of Equity
MicroFuze International plc (AIM: MFZ) announces the issue of 2,248,000 new ordinary shares at 5p
per share in settlement of £112,400 in respect of it's Directors' past services. The shares will
be issued as follows:
Doug Parrish (note 1) Chief Executive Officer 1,638,000
Tim Wall (note 2) Finance Director 610,000
2,248,000
Note 1 Mr Parrish's interest is registered in the name of Trilakes Enterprises Pty Ltd
Note2 Mr Wall's interest is currently a non-beneficial interest held in the name of Horsford Ltd.
Following this issue, MicroFuze will have 151,369,110 ordinary shares in issue. Trilakes
Enterprises Pty Ltd will be interested in 3,138,000 ordinary shares in the Company, representing
2.07 per cent. of the issued share capital and Horsford Limited will be interested in 985,000
ordinary shares in the Company, representing 0.65 per cent. of the issued share capital.
Application will be made for the new ordinary shares to be admitted to AIM, which is expected to
take place on 11 June 2007.
Issue of Options
MicroFuze International plc (AIM: MFZ) announces the issue of 8,310,000 options to the directors
of the Company, with an exercise price of 10p, representing a 100% premium to the current market
price of the underlying shares, and a term of 5 years from the date of issue, as follows:
Name Position 10p Exercise Price
Sandy Barblett (note 3) Ex-Commercial Director 3,000,000
Harley Grant CEO of ATC and Technical Consultant to MFZ 2,000,000
Jeff Henry President and COO of ATC and Technical 2,000,000
Consultant to MFZ
Art Greenburg Ex- President of MicroFuze Americas 1,000,000
Kaylan Holmes Ex-General Manager of MicroFuze Americas 200,000
Mike Dureau Technical Consultant to MFZ 110,000
Total Options 8,310,000
Note3 Mr Barblett's interest is currently a non-beneficial interest held in the name of Entopia
Consultants Ltd.
The above options have been issued either as an incentive to current employees or to honour
previous commitments to past employees. It should be noted that the Company has not been in a
position to issue some of these options earlier due to closed periods.
Change of Registered Address
The Company has changed its registered address to Castle Chambers 43 Castle Street Liverpool L2
9TL.
For further information:
MicroFuze International plc www.microfuze.com
Doug Parrish, Chief Executive Tel: +44 (0)20 7016 5100
parrish@microfuze.com Mob: +44 (0) 7789 373 292
Nominated Adviser: Nabarro Wells & Co Limited
John Wilkes / Hugh Oram Tel: +44 (0)20 7710 7400
Media enquiries:
Positive Profile
Henry Gewanter Tel: +44 (0)20 7489 2028
henryg@positiveprofile.com Mob: + 44 (0) 7774 22 88 45
MicroFuze International plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.